MONTREAL, CANADA -- (MARKET WIRE) -- December 14, 2006 -- ART Advanced Research Technologies Inc. ("ART")(TSX: ARA) announced today that it received an unconditional Health Canada Medical Device Licence to commercialize its SoftScan® optical breast imaging device, effective immediately. ART is now in a position to make SoftScan accessible to Canadian hospitals and clinics to help improve the diagnosis of breast cancer for thousands of women in Canada.
